Skip to main content
OpenTrials
Completed

NCT Number: NCT04540081

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colon Cancer Bacterial Infections Bacterial Infections and Mycoses Behavior Blood-Borne Infections Body Weight Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Communicable Diseases DNA Virus Infections Digestive System Diseases Digestive System Neoplasms Flaviviridae Infections Gastrointestinal Diseases Gastrointestinal Neoplasms Health Behavior Hepatitis Hepatitis C Hepatitis, Viral, Human Herpes Zoster Herpesviridae Infections Infections Intestinal Diseases Intestinal Neoplasms Liver Diseases Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Bacterial RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Respiratory Tract Neoplasms Shingles Signs and Symptoms Thoracic Neoplasms Tobacco Use Cessation Varicella Zoster Virus Infection Virus Diseases

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UC Davis Medical Center

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

Exclusion criteria

  • Patients outside of the age limits or have an established PCP.

Treatment and study plan

Epic Healthy Planet Population Health Module

Other

Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations

Primary outcomes

  1. Overall Adherence to CLOVER Metrics

    Time frame: 6 months

    This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for

Secondary outcomes

  1. Colon cancer screening

    Time frame: 6 months

    Proportion of eligible patients who completed colon cancer screening.

  2. Lung cancer screening

    Time frame: 6 months

    Proportion of eligible patients who completed lung cancer screening.

  3. Tobacco cessation counseling

    Time frame: 6 months

    Proportion of eligible patients who completed tobacco cessation counseling.

  4. Obesity counseling

    Time frame: 6 months

    Proportion of eligible patients who completed obesity counseling.

  5. Pneumonia vaccination

    Time frame: 6 months

    Proportion of eligible patients who completed pneumonia vaccination.

  6. Shingles vaccination

    Time frame: 6 months

    Proportion of eligible patients who completed shingles vaccination.

  7. Hepatitis C screening

    Time frame: 6 months

    Proportion of eligible patients who completed hepatitis C screening.

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Collaborators

  • University of California, Irvine

Registry information

Acronym: CLOVER

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Sep 7, 2020
Registry last updated
Dec 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.